Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions.

NIH study finds routine lab tests fall short in diagnosing long COVID

A National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people

August 13, 2024

Nucleic acids in food show potential to inhibit cancer cell growth

When people eat, they ingest the nucleic acids that reside in all living things. The compounds in these acids could inhibit the growth of cancer

August 29, 2024

CVD Toll From Sugary Drinks; Migraine Tx and Heart Risk; Baby Heart Xenotransplant?

An estimated 2.2 million new cases of type 2 diabetes and 1.2 million new cases of cardiovascular disease (CVD) each year around the world were

January 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.